Enfin disponible en Europe, grâce à une étonnante formule France, 100% naturelle, vous pouvez maintenant dire stop à vos problèmes d’impuissance et à vos troubles de la virilité. Cette formule révolutionnaire agit comme un véritable achat levitra
naturel. Ses résultats sont immédiats, sans aucun effet secondaire et vos érections sont durables, quelque soit votre âge. Même si vous avez plus de 60 ans !
Microsoft word - cam_tb strategic plan_2011-2015 fina draft
Kingdom of Cambodia
Nation Religion King
NATIONAL HEALTH STRATEGIC PLAN
TUBERCULOSIS CONTROL IN THE KINGDOM OF
National Center for Tuberculosis & Leprosy Control
Ministry of Health,
1. BURDEN OF TB IN CAMBODIA
Despite significant achievements made by the national TB programme in the past decade,
Cambodia still remains one of the 22 high TB burden countries in the world. The prevalence
of all form of TB was estimated at 664 /100,000 pop in 2007. The incidence of all form of TB
was estimated at 495 /100,000 pop in 2007, accounting for around 70,000 people with new
active TB each year including about 30,000 people with infectious forms of tuberculosis (1).
The prevalence of HIV in TB patients, though declining over the years, still remains high at
6.4 % (2). The rate of Multi-drug resistant TB (MDR-TB) is not high in Cambodia. However,
preliminary results from the second national drug resistance survey (2007) indicate an
increase in the prevalence of MDR-TB since the first survey; the prevalence of MDR-TB
among new smear-positive cases was 1.4 % in 2006 and that of re-treatment cases 10.5%
(3). 2. TB CONTROL INFRASTRUCTURE NETWORK
The national TB programme (NTP) network covers the entire public health care delivery
system which includes the National Centre for Tuberculosis and Leprosy Control (CENAT) at
the national level, all 24 provincial and city health departments, 77 operational districts and
1070 health facilities, which include 80 referral hospitals and 960 health centres(4) . Each
level has designated TB staff and is responsible for specific functions of the TB programme
as summarised below: Central level:
Overall responsibility for the NTP lies with CENAT which is manned totally by
around 200 staff out of which 30 full time staff are working for NTP headquarters and
responsible for developing policies and plans, training, supervision, monitoring the TB
programme, and coordinating with other partners supporting the TB programme. CENAT
also houses a referral chest hospital with 130 beds and the National TB Reference
Laboratory (NTRL). Provincial level:
Every province has a provincial TB Medical Supervisor, in charge of TB
control activities in the province, and a TB Laboratory Supervisor, appointed by the
provincial health director. They are responsible for all TB services in the provinces,
especially for planning, coordination, resource mobilization within the province and regular
supervision of the ODs and health centres. Operational district (OD) level:
Every OD has an OD TB supervisor. Their responsibilities
are to maintain the OD TB registry, planning and coordination and provide supervision to
the health centers every month. ODs have referral hospitals, which have TB units with beds,
a few TB staff and TB laboratories for smear diagnosis. ODs also have former district
hospitals that have TB units and TB laboratories too. In total, there are 210 microscopic
centers (MC) in the country.
Health Center level:
DOTS in the health centres are implemented by cross-trained general
health workers. Usually, two workers in each health center (HC)receive three-day training on
DOTS, including that on smear-making. They are designated as TB health workers at HC
level. Nearly 10% of all health centers have TB laboratories. These HCs are staffed with
three to four TB health workers including at least one responsible for microscopic work Laboratory network:
The National Reference TB Laboratory(NTRL) , under the NTP and
located within the same premise as CENAT has about 16 staff, provides culture and drug
sensitivity testing facilities, and is responsible for planning, training and supervision for TB
laboratory services. It is also responsible for external quality assurance of sputum
microscopy services which is provided through a network of 204 laboratories covering the
entire country. In addition to the NTRL, two provincial TB laboratories (at Battambang and
Kampong Cham) perform TB cultures.
The NTP has mobilised support from a large number of development partners for financial
and technical assistance as well as for implementation of activities. Through Community
DOTS (C-DOTS) and Public Private Mix (PPM) initiatives, a network of community
volunteers (usually members of Village Health Support Groups) as well as private health
care providers have been engaged to refer TB suspect s to public health facilities and to
serve as treatment observers for patients in their own communities 3. THE NATIONAL TB PROGRAMME (NTP) AND ITS ACHIEVEMENTS
In 1994, the Ministry of Health adopted the WHO recommended Directly Observed
Treatment, Short-course (DOTS) strategy, hailed as one of the most cost-effective health
interventions for developing countries. The National Committee for TB control was
established a year after, honourably headed by the Prime Minister, clearly demonstrating the
political commitment from the government.
During the past 15 years, the NTP was able to accomplish remarkable achievements with
the strong support of its partners. 100% coverage of DOTS services at health center level
was attained by the end of 2004; since 1995 the NTP has been able to maintain high cure
rate of over 85%.The program attained the 70% case detection rate by 2005 as planned.
Though the case detection rate of smear positive TB cases has slightly declined since then,
the overall number of TB cases continues to increase, partly because of increased focus and
capacity for diagnosing smear negative TB (18,892 in 2000, 36,121 in 2005 and 40,199 in
2009). In 2009,the NTP achieved a new smear positive case detection rate of 62% and
treatment success rate of 94%. The treatment success rate has been sustained above 90%
for the past 13 years.
Other achievements by program components are summarised below: Community DOTS(C-DOTS):
Introduced in 2002 as pilotting, C-DOTS was expanded
gradually to cover more than 70% of the health centres by 2009. C-DOTS project was
evaluated in 2008 and was found to have met its main objective of improving access to TB
patients by employing community volunteers to provide DOT to patients within their
communities. Additionally, community volunteers play an important role in increasing
awareness about TB, identifying and referring TB suspects to the health centres thereby
promoting earlier case detection.
started in 2003, good progress has been made in expanding TB/HIV collaborative
activities which increased to cover 74 of 77 operational districts in 2009. The fourth national
sero-prevalence survey showed a further decline in HIV prevalence among TB patients from
11.8% in 2003 to 6.4% in 2009. The uptake of HIV testing among TB patients reached more
than 70% and provision of OI/ART services for co-infected patients showed improvements.
Initiatives to reduce the burden of TB among PLHA have begun with the development of TB-
HIV clinical guidelines,the revision of National TB/HIV framework, and the standard
operating procedures for the three I's strategy ((Intensified TB case finding among PLHA,
Isoniazid Preventive therapy (IPT), and Infection control). Public Private Mix (PPM)-DOTS:
In Cambodia, the PPM-DOTS model involves referral of
suspected TB cases by private providers (mainly pharmacies, cabinets and clinics) to public
health facilities for diagnosis and treatment. By 2009, this was implemented in 39 ODs of 11
provinces. PPM has contributed to the case detection rate of the NTP and in restricting the
sale of anti-TB drugs in private pharmacies, thereby contributing to preventing the spread of
MDR-TB. TB in Congregate settings:
In recent years, NTP has focussed on and congregate settings
such as prisons and garment factories. Standard Operating Procedures for the management
of TB in prisons is under development. With support from partners, by mid 2009 nine of the
26 prisons are now providing TB services. Activities aimed at increasing awareness on TB,
referrals for testing of those reporting TB symptoms, provision for DOT in the workplace are
ongoing in 16 garment factories. Childhood TB.
NTP has initiated activities to address TB in children. The first stand-alone
National guidelines for childhood TB was developed in 2008 and some trainings have been
conducted. Pilot projects are being implemented in 6 ODs to strengthen the management of
childhood by building capacity and provision of adequate supplies (PPD, X-ray films) for
diagnosis of childhood TB, streamlining the referral process, promoting systematic contact
tracing and intensified supportive supervision. The proportion of children notified under the
NTP has increased from around 1% in 2000 to nearly 10 % of the total cases notified in
2009. Since 2008, peadiatric formulation of anti-TB drugs has been made available through
a grant from the GDF. MDR-TB:
Pilot projects on MDR-TB, including a Green Light Committee (GLC) approved
project, are being implemented by NGOs in collaboration with the NTP since 2006. The NTP
was recently approved by the GLC for procurement of concessionally priced second line
drugs. Very soon, the NTP, with support from its partners will expand the current pilots to
implement programmatic management of drug-resistant TB. Improving diagnosis:
Quarterly external quality assurance activities for sputum microscopy
have expanded gradually to reach 100% by 2009, and along with that the performance of
the labs has gradually improved. Diagnostic committees for smear negative TB are
functioning in 10 of 24 provinces to improve the quality of diagnosing smear negative and
extra-pulmonary cases. Fluorescent microscopy has been introduced in seven labs, and one
of the three culture lab is already performing liquid cultures with plans to also expand to the
other two culture labs by 2010. X-Ray services have become more widely available, and
several trainings were conducted to build capacity for taking good X-rays as well as for
reading them. Drug management:
NTP successfully switched to the use fixed dose combination drugs in
2008. The programme has also been successful in ensuring uninterrupted supply of good
quality drugs procured from WHO-prequalified suppliers as well as grants from the Global
Drug Facility (GDF). No stock out has been reported for many years now.
The many achievements of the NTP was made possible due to the strong support and
collaboration from its partners. These include local authorities and communities, WHO, JICA,
USAID, US-CDC, CIDA, World Bank, RIT/JATA, WHO, TBCAP, US-CDC, MSF-F, PATH,
FHI, CHC, CRS, SCA, PFHAD, RHAC, RACHA, URC, SHCH, Vor-ORT.
4. ISSUES AND CHALLENGES
Considering the continued high burden of TB, the main challenge is to consolidate, sustain
and further improve the TB program for many more years, if not decades. This includes
political commitment for continued priority to control TB, mobilising adequate financial
resources and a competent and motivated work force to implement the program over the
coming years. Some of the specific technical challenges are summarised below:
As C-DOTS is assisted by around 10 partners, coordination
and resources to maintain the activities among these partners are of critical importance. TB/HIV co-infection:
Despite the decline, TB/HIV co-infection continues to be high with
6.4% of TB patients testing positive for HIV in the 2009 survey. Intensified case finding
among PLHA, and INH preventive therapy are not routinely provided in HIV services.
Diagnosing TB among PLHA remains difficult because of limited access to culture facilities,
capacity for clinical management of TB/HIV co-infected patients remains limited, and
linkages between the TB and HIV programmes needs to be strengthened further.
Information system related to TB/HIV requires also further strengthening. PPM-DOTS:
Though promising, PPM has not contributed to the case detection as
anticipated. Other challenges include the high proportion of referred TB suspects that are
lost during the referral process, and the need to expand at least to all urban areas,
particularly for targeting pharmacies to restrict the sales of anti-TB drugs. Laboratory capacity:
The management and technical capacity of the NTRL needs to be
further strengthened to cope with demands for introducing new diagnostic technologies while
addressing needs for ensuring quality of current services including for sputum microscopy,
culture and DST services. Bio-safety of labs, p articularly for those performing culture and
DST needs to be ensured. Diagnostic issues:
Capacity for diagnosis of smear negative TB remains limited. Availability
and quality of X-ray services needs further enhancement and health workers related to this
diagnostic actvities need to be more motivated MDR-TB:
The second national drug resistance survey (DRS) 2006-2007 indicates an
increase in the number of MDR-TB cases. Current projects are still limited to 9 MDR-TB
treatment sites , second line DST is not yet available in the country limiting the option for
individualised treatment regimen. Infection Control (IC):
Following the development of general infection control guidelines by
the MoH this year, the NTP has begun developing SOPs, implementation plans and trainings
for TB-Infection control that are aligned with MoH guidelines as well as the global guidelines.
A number of the health facilities, particularly TB (including MDR-TB) and HIV settings need
to be renovated to minimise the risk of TB transmission. Orientation and trainings on TB-IC
will be needed to increase awareness and prioritise implementation of TB-IC measures.
TB in prisons:
Several surveys as well as routine data from ongoing activities indicate the
high prevalence of TB prisons as compared to the general population. Most of the prisons
are yet to provide TB services; prison facilities do not have the infrastructure to separate
infectious TB patients thus the likelihood of ongoing TB transmission. The SOP for TB in
prison under development will provide clear guidance on way forward, which encompasses
the role and responsibilities of stakeholders concerned. Childhood TB:
Diagnosis of childhood TB is possible only at the referral hospital requiring
time away from work and incurring transportation cost. Systematic contact tracing, including
IPT for eligible children, is resource intensive as it requires outreach work, the benefit of
taking a 6 month course of treatment for a healthy child is not always understood making it
difficult to implement on a wide scale.
5. PURPOSE OF THE STRATEGIC PLAN
The main objective of the strategic plan is to provide priority strategic activities of the NTP
during the next five years based on the strategic directions stated in the National Health
Policies and strategies for TB Control in the Kingdom of Cambodia 20011-15. In general, the
activities are described in broad terms, where applicable specific activities with targets are
mentioned. This strategic plan must be translated to annual action plan for TB control at
national, provincial and district levels.
II. STOP TB STRATEGY and GLOBAL PLAN TO STOP TB
The Stop TB Strategy is the approach recommended by WHO to reduce the burden of TB in
line with global targets set for 2015. The strategy is summarized in TABLE 1
(1). The Stop TB
Partnership's Global Plan to Stop TB 2006-2015 sets out the scale at which the interventions
included in the Stop TB Strategy need to be implemented to achieve the 2015 targets.
: The Stop TB Strategy at a glance VISION
To dramatically reduce the global burden of TB by 2015 in line with the Millennium Development Goals and the Stop TB Partnership targets
• Achieve universal access to quality diagnosis and patient-centred treatment
• Reduce the human suffering and socioeconomic burden associated with TB
• Protect vulnerable populations from TB, TB/HIV and drug-resistant TB
• Support development of new tools and enable their timely and effective use
• Protect and promote human rights in TB prevention, care and control
• MDG 6, Target 6.C: Halt and begin to reverse the incidence of TB by 2015 • Targets linked to the MDGs and endorsed by Stop TB Partnership: -
2015: reduce prevalence of and deaths due to TB by 50%
2050: eliminate TB as a public health problem
1. Pursue high-quality DOTS expansion and enhancement
a. Secure political commitment, with adequate and sustained financing b. Ensure early case detection, and diagnosis through quality-assured bacteriology c. Provide standardized treatment with supervision, and patient support d. Ensure effective drug supply and management e. Monitor and evaluate performance and impact
2. Address TB/HIV, MDR-TB, and the needs of poor and vulnerable populations
a. Scale-up collaborative TB/HIV activities b. Scale-up prevention and management of multidrug-resistant TB (MDR-TB) c. Address the needs of TB contacts, and of poor and vulnerable populations
3. Contribute to health system strengthening based on primary health care
a. Help improve health policies, human resource development, financing, supplies,
b. Strengthen infection control in health services, other congregate settings and
c. Upgrade laboratory networks, and implement the Practical Approach to Lung Health (PAL) d. Adapt successful approaches from other fields and sectors, and foster action on the
4. Engage all care providers
a. Involve all public, voluntary, corporate and private providers through Public-Private Mix (PPM) approaches
b. Promote use of the International Standards for Tuberculosis Care (ISTC)
5. Empower people with TB, and communities through partnership
a. Pursue advocacy, communication and social mobilization b. Foster community participation in TB care, prevention and health promotion c. Promote use of the Patients' Charter for Tuberculosis Care
6. Enable and promote research
a. Conduct programme-based operational research b. Advocate for and participate in research to develop new diagnostics, drugs and
III. NATIONAL HEALTH POLICIES AND STRATEGIES FOR TB
This Strategic Plan has been developed to complement the National Health Policies
and Strategies for Tuberculosis Control 2011-2015 which is aligned to the wider
overall National Health Strategic Plan 2008-2015 as well as the Stop TB Global
Strategies and Plan 2006-2015. It is the third paper of its kind formulated by the NTP
in consultation with its partners.
The National Health Policies and Strategies for Tuberculosis Control provides policy
and strategic directions of the Ministry of Health (MoH) concerning the control of TB
in the kingdom, covering the period from 2011 to 2015 to contribute to the attainment
of the goals and objectives of the overall National Health Strategic Plan, and thereby
contribute to attaining MDG targets by 2015. The document covers 7 policy
statements and about 50 strategic directions. The 7 policy statements include:
- The National Center for Tuberculosis and Leprosy Control (CENAT)
assumes overall responsibility for the National Tuberculosis Control Program (NTP) to be implemented countrywide through the health care delivery system in Cambodia.
- The National TB Control Program ensures the existence of clear and
practical Policies, Strategies, Plans and guidelines for TB control.
- The National TB Control Program ensures, according to the national protocol
and guidelines and in line with the International Standard of Tuberculosis Care, good quality, diagnostic, curative, preventive and promotive TB services, which are accessible to the community and free of charge.
- The Ministry of Health will seek to ensure that financial inputs are fully
mobilized from all sources for TB control activities and used effectively and efficiently in TB control, and that there is uninterrupted supply of good quality drugs 1st and second line anti-TB drugs, TB diagnosis and laboratory equipment and supplies.
- The Ministry of Health will seek to ensure that priority is given to investment
in human and material resources for TB control activities.
- The NTP will strengthen the information system and promote research
activities in order to better manage the program. Research topics include the epidemiological patterns of the disease, health-seeking behavior and other issues related to TB in Cambodia.
- Both internal and external partnership should be seen as a core element in
achieving NTP objectives. All resources should be mobilized and coordinated in such a way that would improve TB control activities at all levels within and outside the health care system.
IV. STRATEGIC PLAN FOR THE NTP 2011-2015
The main goal of the NTP is to contribute to improving the health of the
Cambodian people in order to contribute to socio-economic development and poverty reduction in Cambodia by reducing the morbidity and the mortality due to tuberculosis.
The overall objectives for 2011-2015 are to ensure equity and universal
access to quality TB services; maintain a high cure rate of more than 85%;and
reduce the prevalence of TB and death due to tuberculosis by 50 % by 2015
relative to the 1990 figures in order to contribute to attaining the Millennium
Development Goals (MDG). 2. OBJECTIVES
Objective 1. To consolidate and maintain high quality TB services nationwide in order to
achieve universal access to quality diagnosis and treatment.
Objective 2. To improve and ensure equitable access to TB services focusing on the poor
and community participation.
Objective 3. To respond to TB/HIV co-infection, drug-resistant TB, childhood TB and other
high risk groups and challenges.
Objective 4. To ensure adequate resources and strengthening coordination for TB control
and contribute to health system strengthening.
Objective 5. To strengthen Monitoring and Evaluation System and to promote research
activities for TB control
3 .STRATEGIC ACTIVITIES AND EXPECTED RESULTS
Objective 1. Consolidate and maintain high- quality TB services nationwide
(i) Capacity and quality of diagnosis for TB assured and increase of TB cases notified.
(ii) Improved care and support to TBH patients of all forms of TB, including smear –ve TB. Components:
Improving TB diagnosis and notification
• Promote early case detection by using various tools and approaches which include
active case finding and contact investigation in communities and among high risk groups.
• Laboratory strengthening for case detection through quality-assured bacteriology ,including
culture and DST), adoption of globally recommended new diagnostic tools/methods such as LED Fluorescence Microscopy, liquid cultures and line probe assays.
• Number of Microscopy Centres will be increased to account for population growth in order to
• Culture laboratories will be increased from the existing 3 to at least 5 designated culture
• Use of LED Fluorescence Microscopy will be expanded to all provinces.
• NTRL will gains capability to perform quality assured DST services for both first line anti-TB
drugs and if appropriate for second line anti-TB drugs.
• Ensure all TB laboratories in the country will meet required bio-safety levels/requirement
depending on the services performed, including renovation of the NTRL to meet Bio safety level 3 requirement; and test results are assured through implementation of quality assurance programmes.
• Concerning EQA for sputum microscopy, it is expected by 2015, at least 90% of TB
labs will perform adequately according to national standards. In addition, quality assurance programmes for new diagnostics will be implemented.
• Linkages between the health centres and TB microscopy laboratories and designated
culture laboratories, as well as between designated culture laboratories and the National Reference laboratory will be strengthened. MCs will be clustered to link with each designated TB culture laboratory. The referral network for sample collection, transportation, delivery of test results for all laboratory services will also be strengthened.
• Improved diagnostic capacity for smear negative and extra-pulmonary TB will be
scaled up to cover the entire country through trainings, establishments of TB diagnostic committees, implementation of SOPs, and provision of adequate equipments and supplies.
• Given the importance of chest radiography to assist in diagnosis of smear negative
TB cases, including TB/HIV co-infected cases; NTP will further build capacity to provide quality assured radiography services nationwide.
• NTP will explore the possibility of introducing digital X-rays that could be stored and
used for providing on the job training during supervision, and also sent by email to experts at CENAT for consultation, when required.
Patient-centred care and support
• Engage with TB patients to assess their needs and jointly plan provisions for their
treatment prioritising the convenience of patients, and giving emphasis on the provision of DOT at health center and in the community.
• Make services patient- friendly by considering the needs of patients including
opening hours of TB services, turn-around time for results, waiting time, distances to be travelled, improved inter-personal communication skills of health workers etc
• Provide incentives and enablers to TB patients, which include nutritional/food
support, transport vouchers, other social support, while carefully considering the impact of such initiatives and its sustainability.
• Promote the use of Patients Charter, identify champions among ex-TB patients and
encourage utilization of their services as DOT watchers, community educators, social mobilization activities etc.
• NTP will continue to promote the use of physiotherapy to patients needing such
services, such as those with poor pulmonary functions as sequelae of TB, as a supplement to curative care at hospital level.
• Educate patients to promptly identify and report adverse drug reactions, and build
capacity of health centre staff to manage common side effects
Objective 2. Improve and ensure equitable access to TB services focusing on
the poor and community participation
(i) Increased utilization of TB services by the poor population
(ii) TB services more accessible to the community
(iii) More involvement of non-government health care workers in TB control
(iv) Improved ACSM activities, contributing to more case identification and better care.
(i) TB and poverty
• Ensure free of charge services for TB diagnosis and treatment in public health
services by reinforcing the implementation of the policies and strategies, through dissemination workshops, issue of legislature papers like Prakas (declaration) or circulars, supporting logistics and incentives.
• Engage in broader initiatives at the MoH level such as health equity funds and other
health financing schemes, pursue policies that reduce patient's out of pocket spending on health care and related costs for additional services beyond those provided free by the NTP.
• Situation analysis to identify barriers in accessing to TB services, including patient
and health system delays. Design and implement interventions to address identified barriers, particularly targeting the poor.
• Explore possibilities to embark on innovative and sustainable approaches for pro-
(ii) Community-DOTS (C-DOTS).
• Expand and sustain community DOTS to cover the whole country based on the
national Community DOTS Guidelines by collaborating with development partners, and mobilising community members like community leaders, village health support group members (VHSG), and former TB patients to provide C-DOTS services.
• Undertake studies to assess and document C-DOTS implementation, including the
role of C-DOTS in reducing diagnostic delays, improved treatment outcomes and case detection, improved geographical and economic access, increased awareness and reduced stigma in the community.
• Strengthen the NTP referral system both horizontally and vertically, including
linkages between C-DOTS and PPM DOTS as well as other priority areas within the NTP network, which encompass the link between national and referral hospitals to the health centres.
• Promote integrated management of C-DOTS with other specific interventions at the
HC and community level, including Childhood TB and MDR-TB, to leverage resources and improve cost-efficiency.
(iii) PPM and ISTC
• Disseminate national PPM-DOTS guidelines to all care providers (public and private),
organise training and workshops, and oversee delivery of services through a mix of providers based on the local context.
• Strengthen the technical working group for PPM and C-DOTS, with representation
from NGOs and other partners implementing or supporting these initiatives, to regularly review and coordinate activities.
• Further promote partnership with private sector, NGOs, IOs and other government
institutions for TB control, including the new concept of TB in workplace (corporate sector).
• Engage with professional societies in Cambodia, including Cambodia Medical
Council, Cambodia medical Council and Pharmacist Association of Cambodia to promote the use of the International Standards for TB Care (ISTC), and to monitor adoption of the Standards and restrict the sales of anti-TB drugs, particularly by members of these societies.
• Review initiatives in garment factories and other workplaces, to document lessons
(iv) Advocacy, Communication and Social Mobilization (ACSM)
• Develop strategic plan for ACSM and implement operational plans tailored to meet
specific objectives and target audiences considering relevance to the local context.
• Promote advocacy activities, especially through the celebrations of world TB day at
all levels as well as during some events such as conferences of various fields including NTP meetings/workshops.
• Enhance TB health education through both mass media and interpersonal health
education like peer group education, health education through health facility staff at schools, pagoda, and communities .
• Improve communication between patients and service providers.
• Collate available information or conduct KAP surveys to identify challenges, priority
populations and key behaviour targets to design ACSM strategies.
• Engage with community and religious leaders (e.g. monks, achars
societies, faith based organizations, schools and work places, former TB patients etc to generate awareness and build consensus and social commitment to fight stigma and eliminate TB as a public health threat.
• Monitor and evaluate the outcome or impact of ACSM activities including through
Objective 3. To respond to TB/HIV co-infection, drug-resistant TB, childhood TB and
other high risk groups and challenges
(i) Increased uptake in HIV testing of TB patients and uptake of ART of TB/HIV patients
(ii) Nationwide coverage for testing and treatment of MDR-TB patients
(iii) Improved access and care of childhood TB
(iv) Provision of TB services in all prisons
(iv) All health facilities implement appropriate TB-IC measures Outputs/components.
(i) TB/HIV co-infection
• Expand collaborative TB/HIV activities to the whole country in partnership with
NCHADS and other partners, particularly for implementation of the revised framework for TB/HIV and the recently developed SOP for the Three I’s Strategy (Intensified case finding, INH preventive therapy, and Infection control).
• Strengthen linkages with the HIV/AIDS programme to increase the uptake of HIV
testing among TB patients to reach more than 80% by 2015.
• To promote the uptake of ART to all identified TB/HIV patients.
• For TB/HIV co infected patients to be channelled into continuum of care/home-based
care services so they may avail of OI/ART services and peer group and community support.
• To build staff capacity on TB/HIV through training and re-training on both TB/HIV
• Strengthen TB/HIV monitoring and evaluation systems to improve quality of data.
Encourage quarterly data triangulation at OD level between OD register and OI ART register and advocate for adoption of standardized TB/HIV indicators reporting.
• Continue with periodic surveys of HIV prevalence among TB patients to monitor the
situation and impact of TB/HIV collaborative activities every two to three years.
(ii) Multi-drug resistant TB
• Based on the ongoing pilots and strategically formulated PMDT plan, from 2011 start
the notional programmatic management of drug-resistant TB (PMDT) with the aim of achieving the country wide coverage by 2015 with at least 25 treatment sites.
• The number of labs for culture and DST services will be designated for grouped
specialised MDR-TB sites to ensure quality.
• Strengthen the referral systems for patients, transportation of diagnostic specimens,
drugs and other logistics, to achieve this.
• Secure adequate resources for management of drug-resistant TB including for
laboratory services, second line drugs, management of side effects, patient support, and to implement appropriate infection control measures.
• Collaborate with in-country partners as well as global partners such as the Green
Light Committee and Supra-National Reference Lab network to avail of technical assistance, concessionally priced second line drugs, and assure quality of services.
• Coordinate PMDT with other activities, particularly with C-DOTS for identification and
referral of MDR-TB suspects and community based management of cases with the support of community volunteers.
• Mainstream the diagnosis and treatment of children with TB as part of routine NTP
activities, including community based screening and management of childhood TB , TB/HIV, and MDR-TB.
• Include childhood TB in regular supervision, and secure adequate supplies including
for tuberculin skin test (TST) and paediatric formulation of TB drugs.
• Establish services and build capacity of staff to address specialised expertise needed
• Strengthen the referral system from the Health Centre to Referral Hospital, which
may include support for paediatric TB suspect and accompanied persons to access TB diagnosis and treatment services.
• Conduct systematic contact tracing and investigation of children who are household
contacts of TB cases, to identify those requiring TB treatment and for the others to receive IPT, particularly children below five years of age.
• Collaborate with other national programmes and paediatric hospitals in both public
and private sector, to strengthen the management of TB in children.
• Promote BCG vaccination to be delivered to all children under the national
Other high risk groups
Disseminate the SOP for providing TB services in prisons, factories and other
congregate settings, which also addresses TB-Infection control issues given the high risk of TB transmission in such setting.
Evaluate existing initiatives in prisons to document lessons learnt and inform future
Collaborate with the Ministry of Interior and partners to expand TB services in
prisons. Expand current activities to cover all prisons and sustain these activities through this plan period.
Conduct situational analysis and studies to identify high risk groups/populations and
determine the barriers which prevent access to TB control.
Determine the outcome and impact of these activities and develop the most
appropriate ways for delivering such services in tandem with ongoing initiatives.
Promote case finding, including active case finding among identified high risk groups
and populations. This could include urban poor populations, migrants, smokers, diabetics, old age, children who are close contacts of infectious TB patients, HIV positive individuals, those in congregate settings, including orphanage.
(v) Infection control (IC) in health facilities, congregate settings and households
Develop SOPs, and implementation plans for TB-IC aligned with policies and
guidelines on general infection control from the Ministry of Health as well as TB-IC global guidelines.
Organise sensitization workshops and trainings to build commitments and capacity
for putting in place necessary measures for IC in health care facilities and congregate settings.
Conduct facility assessments, develop and implement TB-IC implementation to
provide safe working environment for health staff and patients availing of health services.
Use appropriate IC control measures including managerial, administrative
environmental and individual interventions to address IC problems for each setting. These include interventions in health facilities, congregate setting and communities
Secure adequate resources to undertake necessary renovations, provide equipments
and supplies, to promote and provide safe working environment for health care staff and patients.
Design and implement effective communication strategies targeting health care
workers, patients and their families, and visitors of hospitals to raise awareness and take measures to protect themselves and reduce the risk of TB transmission in their environment.
(vi) Practical Approach to Lung Health (PAL)
Mobilize technical and financial resources to conduct a situational analysis, develop a
Implement pilot plan to demonstrate the technical and operational feasibility of
Practical Approach to Lung Health and its contribution to the national TB programme. Develop and implement scale-up plans if determined to be successful and feasible.
Objective 4. To ensure adequate resources and strengthening coordination for TB
control and contribute to health system strengthening.
(i) Adequate resources including human, material, drug and financial for full implementation
(ii) Strengthened programme leadership, and collaboration with partners
(iii) Planning and implementation of the NTP activities aligned and coordinated within the
overall health system Outputs/components.
(i) Political commitment and resource mobilisation:
• Advocacy with government and partner leaders in the country to maintain TB control
as a high priority, mobilize greater civil society engagement of other government institutions, professional and civil societies in TB control.
• Advocate with concerned national authorities to sustain and increase domestic
allocations to the budget of the TB programme and to ensure adequate staff are assigned for implementing the program.
• Engage with potential donors to widen the donor base and advocate for continued
and increased funding from existing donors.
• Apply for fund from various donors, including future rounds of Global Fund to secure
adequate funding for full implementation of this plan.
(ii). Policies, Plans and Guidelines
• To develop and /or revise and disseminate national health policies and strategies,
plans and guidelines for TB control through routine channels and other forums, such as meetings and workshops.
• To develop a 5-year strategic plan for strengthening the National TB Reference
Laboratory (NRL) and all the other TB laboratories in the NTP network.
• To develop or revise, in collaboration with the National Center for HIV/AIDS,
Dermatology, and STD (NCHADS) and partners concerned, specific strategies and
guidelines, etc, for addressing TB/HIV issues, and to formulate and implement action plan to translate these strategies and guidelines into action.
• To revise the technical guidelines/SOPs , including treatment protocols and training
• To regularly develop annual action plan for TB control at central, provincial and
district levels taking into account the changing situation and the practical needs and budget required as well as funding gap.
• To closely monitor and regularly evaluate the implementation of health policies and
strategies, plan and guidelines for TB Control.
• To be involved and provide inputs concerning TB control into the plan and policy
development of the overall health sector and other partners.
(iii). Procurement and supply management of FLD, SLD, Lab reagents other logistics
• Ensure availability of quality-assured first and second line anti-TB drugs and other
logistics that are quality-assured, in adequate quantities including buffer stocks.
• Maintain a buffer stock of 9 months requirement of first line drugs and TB lab
reagents at the national level and 3 month buffer stock at OD level at all times.
• Maintain a buffer stock of 6 months requirement of second line drugs at the national
level and 2 month buffer stock at OD level at all times.
• Utilize and collaborate existing mechanisms in the health system including other
departments in the Ministry of Health such as the Department of Drugs Food and Cosmetics, the Central Medical Stores, National Laboratory for Quality Control of Drugs to strengthen pharmaceutical management of anti-TB drugs and other NTP related logistics.
• In collaboration with other MoH departments and institutions, implement a quality
assurance plan for TB medicines, ensure all first and second line anti-TB drugs used in the programme are included in the national essential medicine list and registered by the Department of Drugs and Food, Ministry of Health, if required.
• Build capacity of Provincial and OD TB supervisors to ensure correct ordering,
storage, distribution, and use of anti-TB drugs in their areas of operation. Health personnel will ensure that TB drugs are used according to the national protocol and adhere to the rational use of drugs.
(iV) Human Resource Development
• Formulate HR planning for TB control with assessment of current HR situation to
identify gaps both in terms of numbers, distribution, and competency of staff for implementing the NTP, including for new or additional initiatives, considering additional support that is currently available through NGOs and other partners, taking into account sustainability.
• Build capacity of TB health workers to perform their functions effectively and provide
opportunities for staff development and continuing training, including through international trainings, study visits, conferences and meetings.
• Explore appropriate measures to address staff motivation, including both monetary
and non-monetary incentives like opportunity for individual capacity development, providing safe workplaces, and good working conditions.
• Include trainings on the national TB programme, and the International Standards for
TB Care in the curriculum of health care professional trainings (doctors, nurses, pharmacist, laboratory technicians etc).
(v) TB program leadership and coordination:
• Further strengthen CENAT to provide overall stewardship for TB control activities in
the country, working together in close coordination with partners.
• Mobilise technical assistance, both long and short-term to assist and build capacity
• Strengthen existing mechanisms for partnerships and collaboration by organising
regular meetings of the Inter-Agency Coordination Committee, and the various Technical Working Groups. Establish TWG for additional programme areas as needed.
• Seek possibility of creating a national Stop TB partnership.
• Improve coordination of TB control activities at the province and OD level, including
the strengthening or establishment of coordinating mechanism.
• Link up existing coordination mechanism in the country to the global TBTEAM
initiative as means to seek and coordinate technical assistance missions in the country.
• Collaborate with relevant ministries, programmes and departments including the
Department of Drugs and Food, Central Medical Stores, Department of Planning, NCHADS, Department of Health Promotion, Ministry of Interior, Ministry of Education, Ministry of National Defence, Ministry of Religion, and others to implement cross- cutting activities identified in this plan.
• Encourage incorporation of a sustainability plan for new initiatives that are likely to be
part of NTP activities at a later stage. Particularly those implemented in project mode with significant additional resources.
(vi) Contribute to Health System Strengthening
Consider opportunities to strengthen health systems in all aspects and levels of programme
planning, implementation and monitoring. Some of the TB technical focus areas, where this
is more likely to be relevant include:
• Information: Strengthen TB data collection, analysis, and reporting systems; build
data management capacity at all levels and thereby contribute to strengthening of the overall health information systems.
- Quality of care: Coordination with Quality Improvement initiatives to improve
- Coordinate TB-Infection control and PAL to contribute to HSS. - Promote the implementation of C-DOTS to contribute to Community System
- Diagnostic services: construction/renovation and equipments to improve
general supplies, implement lab and X-ray QA system for NTP to also strengthen overall diagnostic services in the facilities.
• Medical products and technologies: Coordinate and contribute to MoH initiatives
related to pharmacovigilance, rational use of drugs, quality assurance.
• Financing: Link with MoH’s health financing schemes such as Health Equity Funds,
to improve financial risk protection and coverage of TB patients.
• Health workforce: Coordination with HRD department and Personnel department
concerning specific activities such as HRD plan for TB control, training of TB health workers and related staff , appropriate incentives , staff motivation and distribution as well as retention of staff.
• Leadership and governance: Coordinate planning, policy-making, and management
within the overall framework of the National Health Strategic Plan.
• Infrastructure: contribute to heath infrastructure development of the general health
servies, which include renovation and construction TB/MDR-TB wards as well as TB laboratory facilities.
Objective 5. To strengthen Monitoring and Evaluation System and to promote
research activities for TB control
(i) Reliable recording and reporting system that is timely, complete, and of good quality
(ii) Enhanced capacity of the NTP for conducting operational research
(iii) Surveys conducted to document the impact of the NTP Implementation approaches.
(i) TB program management and supervision
• Organize regular programme reviews including through annual TB conference,
quarterly M&E workshops, meetings etc
supervision from national, provincial and OD levels as an
integral part of support to all key elements of the NTP strategy that also acts as an extension of training and a process for increasing the proficiency and motivation of health workers.
(ii) M&E system and, impact measurement
• Revise the R&R system to capture information on all aspects of the TB program
including PPM, C-DOTS, MDR-TB etc. Enhance information technology (IT) including the use of appropriate database, and use of electronic system.
• Build capacity for data management and promote the analysis, interpretation and use
of TB health information to improve program performance.
• Revised tools for program M&E at all levels including introduction of a peer-review
process for programme evaluation and on-the-job training.
• Continue to publish and disseminate quarterly and annual NTP reports and other
• Conduct NTP Joint program review in 2012
3rd National TB disease prevalence survey in 2015.
3rd national drug resistance surveillance 2014.
• Organize survey of HIV prevalence among TB patients every two to three years.
(iii) Research Activities
• Conduct the 3rd national prevalence survey in 2015. • Identify priority areas for operational research (NTP research agenda) so that all
research activities are aligned to priorities of the NTP, provide information for evidence-based policy decisions, and lead to improvements in programme implementation.
• Some topics that could be considered for operational research include (i) diagnostic
capacity improvement for smear negative TB (ii) TB/HIV: performance of the new diagnostic algorithm for intensified case finding, including IPT; and implementation of Option 2 for HIV testing (iii) health-seeking behaviour of TB patients (iv) design, implement and evaluate appropriate pro-poor strategies (v), active case finding among high-risk groups (vi) contact tracing and investigation, including IPT for children: feasibility and yield (vii) review accuracy of categorization of TB patients (viii) High risk groups and populations: relative risk for TB to better focus and prioritise more vulnerable groups (ix) TB and tobacco.
• Build local capacity in research activities through training workshops and link with
institutions/organizations that could provide ongoing technical support to design the protocol; in data collection, management and analysis; and its dissemination and/or publication.
IV. MONITORING AND EVALUATION
A number of assumptions should be taken into consideration concerning the
implementation of this strategic plan. Since NTP relies strongly on general health personnel and service utilization, the assumption that there will not be much change of the overall health system organization and staffing during the plan period is of critical importance. Another assumption is that the government and major partners will continue to support NTP.
This strategic plan requires close monitoring and evaluation. Regular
monitoring of the plan implementation is paramount importance to ensure that
activities are on the right track to obtaining objectives and targets. Based on
monitoring and evaluation framework indicators, activities need to be closely
monitored through appropriate mechanism. This include monthly and quarterly
supervision, meeting and reports at the peripheral level as well quarterly monitoring ,
meeting and reports by and at the central level.
The strategic plan implementation should be annually evaluated based on main
indicators set for the plan and the annual plan of action (AOP). Midterm evaluation
should be conducted in 2013. Corrections should be made so as to gear towards
attaining objectives by 2015. End-period evaluation should be conducted in mid 2016
prior to the formulation of the next phase plan.
The core indicators and their targets concerning this strategic plan are summarized
in the below table. It should be noted that the targets set for the plan may be revised
based on the outcome of evaluations as well as on the revised epidemiological data.
All All All All All
9 25 25 25 25
25 25 25 25
40,800 40,600 40,400 40,100 39,700
290 284 278 271 264
notification rate (2009)
(CNR )for sm+
136 130 125 119 114
85% >85% >85% >85%
75 80 84 86 >90
status TB patients tested for HIV Proportion
75 80 84 90 >95
80 120 130 140 150
IV. RESOURCE NEEDS AND GAPS
The WHO- Stop TB Planning and Budgeting for TB Control tool was used to
consolidate estimation of the costs of the Strategic Plan. The cost estimates presented here
are relevant at the time of finalising the Plan. However, it should be emphasized that the
process of developing a good strategic plan is iterative as new information becomes availble
or newer approaches are planned and implemented by the programme. This results in
changes to the cost. It is planned to regularly update the the strategic plan, as well as its
costing, over the period of the Plan. It can also provide a sound basis for developing annual
operating plans as well.
An estimated budget of around 210 millions US $ will be needed for the period from
2011 to 2015. The budget for HRD accounts for 25 %, health product and diagnostics about 20%, capacity building including TA approximately 19% , ACSM around 5% and the remaining is for other activities, which include information system, research etc. Community DOTS expansion will require additional resources.
There is an uncertainty in terms of budget availability for the five-year period, because
some negotiations with donors and stakeholders as well as request to donors are taking place, including the request to GFATM round. The estimated financial gap currently is about 80 %.
External resources come from the Global Fund, Japanese Government, JICA, WHO,
USAID, WFP, CDC/GAP, TBCAP/TBCARE and other technical/financial partners including IOs and NGOs.
1. Global Tuberculosis Control 2009.Epidemiology, Strategy ,Finacing.
2. Preminery result .Resull, HIV Sero-prevalence Survey 2009.
3. Preliminary results from the second national drug resistance survey (2007)
4. Tuberculosis Report 2009.CENAT,MoH.
5.Healtth Strategic Plan 2008-2015. 2008, MoH.
Próftafla og lesefni – 5. bekkir Maí 2007 Sum próf eru á skólatíma og eru hluti af venjulegum skóladegi. Tímasetning þeirra er breytileg milli bekkja og mun umsjónarkennari hvers bekkjar láta nemendur vita um tímasetningu þeirra. Sérstakir prófadagar eru 22. – 24. maí og eru tvö próf hvorn daginn með stuttu hléi á milli. Kennsla fellur niður þá daga og n
CHOICE IN HEALTH CLINIC Information for Clients Having a Medication Abortion Welcome to our clinic. This information is to give you an idea of what will happen during your time here. Our Assessment Clinic Nurse will go over the details with you, so you can ask her about anything that is not clear. You will be here for about two hours. A medication abortion is caused by a drug rather than